Andre Engling holds a PhD in Cell/Cellular and Molecular Biology from Ruprecht-Karls-Universität Heidelberg, which they completed in 2006. They began their career as a Scientist at Cellca GmbH from 2006 to 2008, and subsequently held various leadership roles in biopharmaceutical companies, including a Senior Director position at BPC Plasma, Inc. and Senior Biotech CMC Program Lead at Merck Group. Currently, Andre serves as the Head of CMC Microbial Portfolio and oversees Global CMC Project Management at Sanofi, a role they have held since 2021.
This person is not in the org chart
This person is not in any teams
This person is not in any offices